植入物的双功能聚电解质多层涂层:永久的杀菌基与受控释放的治疗剂
Sze Yinn Wong1, Joshua S Moskowitz, Jovana Veselinovic
1Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
Journal of the American Chemical Society
|November 26, 2010
概括
这项研究引入了一种用于医疗植入物的新型双功能涂层. 涂层结合了永久性抗微生物层和可降解层,用于控制药物输送,防止感染和减少炎症.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 植入物相关的感染和炎症是重大的临床挑战.
- 目前的涂料往往缺乏多功能性和受控的治疗释放.
- 层层组装 (LbL) 为先进的生物材料开发提供了一个多功能平台.
研究的目的:
- 开发一种用于植入器械的双功能涂层,将抗微生物特性与局部药物输送相结合.
- 研究两种不同的治疗释放特征:玻尿酸抗生素输送和持续的抗炎药物输送.
- 评估开发的涂层系统的生物相容性和长期疗效.
主要方法:
- 制造一个永久的微生物杀伤性聚电解质多层 (PEM) 基膜.
- 用于药物封装 (gentamicin或diclofenac) 的水解可降解PEM顶部薄膜的构建.
- 在体外评估药物释放动力学,药物疗效和细菌生物膜抑制.
- 使用相关细胞系进行生物相容性测试 (A549,MC3T3-E1).
主要成果:
- 经过几个小时的 Gentamicin 和几天的 Diclofenac 的控制释放.
- 证实药物在释放后有效性的保留.
- 永久的杀菌基膜有效地防止了细菌连接两个星期,并且是生物相容的.
- 即使可降解层被完全侵蚀之后,这种杀菌功能仍然存在.
结论:
- 开发的双功能LbL结构为植入式设备涂层提供了一个多功能平台.
- 这项技术为预防植入物相关感染和控制炎症提供了一个有前途的策略.
- 涂层能够防止生物膜形成并局部提供治疗药物的能力提高了其潜在的临床适用性.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
Biofilms
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...


